EssexBio

Essex-Bio Group

简繁 EN

ANNOUNCEMENTS & SHAREHOLDER INFORMATION

Normative Disclosure, Honest Communication

Select category

ANNOUNCEMENTS SHAREHOLDER INFORMATION

Select time

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012

Date

Title

File

Times

2025-03-04

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2025

58

2025-02-26

NEXT DAY DISCLOSURE RETURN

83

2025-02-10

NEXT DAY DISCLOSURE RETURN

166

2025-02-07

NEXT DAY DISCLOSURE RETURN

170

2025-02-04

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2025

163

2025-01-27

NEXT DAY DISCLOSURE RETURN

190

2025-01-13

NEXT DAY DISCLOSURE RETURN

222

2025-01-08

NEXT DAY DISCLOSURE RETURN

246

2025-01-06

LAST PATIENT LAST VISIT (LPLV) COMPLETED IN AN INTERNATIONAL MULTI-CENTRE PHASE 3 CLINICAL STUDY IN RELATION TO THE CO-DEVELOPMENT OF THE LICENSED PRODUCT WITH HENLIUS FOR THE TREATMENT OF EXUDATIVE (WET) AGE-RELATED MACULAR DEGENERATION

233

2025-01-02

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2024

224

2024-12-30

NEXT DAY DISCLOSURE RETURN

229

2024-12-24

INSIDE INFORMATION APPROVAL TO COMMERCIALISE PRESERVATIVE-FREE UNIT-DOSE SODIUM HYALURONATE EYE DROPS (0.1%) IN THE PRC

239

2024-12-18

NEXT DAY DISCLOSURE RETURN

270

2024-12-17

NEXT DAY DISCLOSURE RETURN

226

2024-12-16

NEXT DAY DISCLOSURE RETURN

242

2024-12-10

NEXT DAY DISCLOSURE RETURN

245

2024-12-04

NEXT DAY DISCLOSURE RETURN

268

2024-12-03

MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2024

241

2024-11-28

NEXT DAY DISCLOSURE RETURN

258

2024-11-27

NEXT DAY DISCLOSURE RETURN

260

This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.

ACCEPT